GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Earnings Yield (Joel Greenblatt) %

Bluemtec Co (XKRX:439580) Earnings Yield (Joel Greenblatt) % : 0.49% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Earnings Yield (Joel Greenblatt) %?

Bluemtec Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩151,765 Mil. Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩746 Mil. Bluemtec Co's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was 0.49%.

The historical rank and industry rank for Bluemtec Co's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XKRX:439580' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -11.02   Med: -6.43   Max: 0.58
Current: 0.54

During the past 3 years, the highest Earnings Yield (Joel Greenblatt) of Bluemtec Co was 0.58%. The lowest was -11.02%. And the median was -6.43%.

XKRX:439580's Earnings Yield (Joel Greenblatt) % is ranked worse than
59.8% of 684 companies
in the Healthcare Providers & Services industry
Industry Median: 2.6 vs XKRX:439580: 0.54

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Bluemtec Co's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Bluemtec Co Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Bluemtec Co's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Earnings Yield (Joel Greenblatt) % Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
Earnings Yield (Joel Greenblatt) %
- - -

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - - - -0.81 0.49

Competitive Comparison of Bluemtec Co's Earnings Yield (Joel Greenblatt) %

For the Pharmaceutical Retailers subindustry, Bluemtec Co's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bluemtec Co's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's Earnings Yield (Joel Greenblatt) % falls into.



Bluemtec Co Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Bluemtec Cos Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2022 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-13022.147/0
= %

Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩746 Mil.



Bluemtec Co  (XKRX:439580) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Bluemtec Co Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bluemtec Co (XKRX:439580) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines